Predicting dimensions of personality disorder from domains and facets of the Five-Factor Model

Journal of Personality
Sarah K Reynolds, L A Clark

Abstract

We compared the utility of several trait models for describing personality disorder in a heterogeneous clinical sample (N = 94). Participants completed the Schedule for Nonadaptive and Adaptive Personality (SNAP; Clark, 1993b), a self-report measure that assesses traits relevant to personality disorder, and two measures of the Five-Factor Model: the Revised NEO Personality Inventory (NEO-PI-R; Costa and McCrae, 1992) and the Big Five Inventory (BFI; John, Donahue, & Kentle, 1991). Regression analyses indicated substantial overlap between the SNAP scales and the NEO-PI-R facets. In addition, use of the NEO-PI-R facets afforded substantial improvement over the Five-Factor Model domains in predicting interview-based ratings of DSM-IV personality disorder (American Psychiatric Association, 1994), such that the NEO facets and the SNAP scales demonstrated roughly equivalent levels of predictive power. Results support assessment of the full range of NEO-PI-R facets over the Five-Factor Model domains for both research and clinical use.

Citations

Apr 11, 2003·Current Psychiatry Reports·R Michael BagbyDeborah R Schuller
Jan 20, 2004·Clinical Psychology Review·Lisa M Saulsman, Andrew C Page
Jul 26, 2002·Psychiatry Research·Irving M RetiGerald Nestadt
Apr 15, 2006·Development and Psychopathology·Mark F Lenzenweger, Danaea Desantis Castro
Oct 15, 2009·Development and Psychopathology·Richard A Depue
Jun 6, 2003·Journal of Abnormal Psychology·Timothy J TrullPaul T Costa
Feb 16, 2005·Journal of Abnormal Psychology·C Emily DurbinKirstin C Moerk
Dec 15, 2005·Journal of Abnormal Psychology·Lee Anna Clark
Jun 29, 2005·Journal of Consulting and Clinical Psychology·Jennifer L SkeemJohn Monahan
Jan 27, 2006·Psychological Bulletin·Paul T Costa, Robert R McCrae
Apr 5, 2003·Psychological Assessment·Jeffrey R VittenglRobin B Jarrett
Dec 25, 2003·Psychological Assessment·Howard N Garb
Feb 11, 2004·Experimental and Clinical Psychopharmacology·Timothy J TrullKenneth J Sher
Aug 24, 2010·Personality Disorders·Leonard J SimmsDaniel F Gros
May 24, 2007·Journal of Personality Assessment·Benjamin J MorascoKatherine A Elder
Jul 3, 2007·Journal of Personality Assessment·Thomas A Widiger, Jennifer Ruth Lowe
Jun 17, 2010·Journal of Personality Assessment·Joshua D MillerPaul A Pilkonis
Jul 19, 2012·Journal of Personality Assessment·Aidan G C Wright
Mar 28, 2012·Journal of Personality Assessment·Jennifer L TapscottLivia Veselka
Apr 6, 2012·Journal of Personality Assessment·Natalie GloverThomas A Widiger
Apr 6, 2012·Journal of Personality Assessment·Whitney L GoreThomas A Widiger
Apr 12, 2012·Journal of Personality Assessment·Stephanie N Mullins-SweattThomas A Widiger
Apr 24, 2012·Journal of Personality Assessment·Douglas B SamuelThomas A Widiger
Apr 24, 2012·Journal of Personality Assessment·Donald R LynamThomas A Widiger
Nov 29, 2012·Journal of Personality Assessment·Joshua D MillerW Keith Campbell
Aug 9, 2013·Journal of Personality Assessment·Robert R McCrae
Feb 3, 2005·Psychological Science·Iftah YovelSusan Mineka
Apr 7, 2011·Assessment·Marina A BornovalovaMatt McGue
Jul 5, 2003·Journal of Personality Assessment·Joni L MihuraJennifer Gunderson
May 21, 2004·Journal of Personality Assessment·Steven K Huprich
Mar 28, 2003·Journal of Personality Disorders·Steven K Huprich
May 21, 2003·Journal of Personality Disorders·Robert F Krueger, Jennifer L Tackett
May 21, 2003·Journal of Personality Disorders·Lee Anna ClarkRobin B Jarrett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.